MedPath

Preemptive Analgesia With Intravenous Paracetamol for Post-cesarean Section Pain Control

Phase 4
Completed
Conditions
Cesarean Section; Dehiscence
Interventions
Drug: Placebo
Registration Number
NCT02369133
Lead Sponsor
Baskent University
Brief Summary

The investigators designed a prospective randomized study to investigate the efficacy of intravenous (IV) preemptive paracetamol on postoperative pain scores, patient satisfaction, total morfin consumption and the incidence of morfin-related side effects in patients undergoing cesarean section.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Patients between the ages of 20-40 years,
  • ASA physical status 1-2 who underwent elective cesarean surgery during general anesthesia were included in the study
Exclusion Criteria
  • A history of allergy to any of the study medications (opiod, general anesthetic agents or paracetamol),
  • history of opioid or paracetamol use,
  • hepatic or renal failure,
  • any psychological disorders,
  • complications during cesarean section and unable to use PCIA device were excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group Paracetamol (Group P),paracetamolDrugs were given intravenously by a nurse unaware of the study 15 min before surgery. Patients in group P (n = 30) received 1 g iv paracetamol
Group Saline (Group S)PlaceboDrugs were given intravenously by a nurse unaware of the study 15 min before surgery. Patients in group S (n = 30) received 100 ml iv %0,9 saline
Primary Outcome Measures
NameTimeMethod
Postoperative pain scores measured by visual analog scale (VAS)Postoperative 24 hours
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath